Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: Studies with ciprofloxacin and moxifloxacin

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3040-3046

  Lismond, Ann ^a   Tulkens, Paul M ^a   Mingeot Leclercq, Marie Paule ^a   Courvalin, Patrice ^b   Van Bambeke, Françoise ^a,c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSTITUT PASTEUR   (France)

^c UCL7370 ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; MOXIFLOXACIN; PROBENECID; RESERPINE;

ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL ACTIVITY; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG ACTIVITY; EUKARYOTE; HUMAN; LISTERIA MONOCYTOGENES; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROKARYOTE; WILD TYPE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; CELL LINE; CIPROFLOXACIN; DRUG RESISTANCE; DRUG RESISTANCE, BACTERIAL; HUMANS; LISTERIA MONOCYTOGENES; MACROPHAGES; MEMBRANE TRANSPORT PROTEINS; MICE; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; QUINOLINES;

EID: 50949093750     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00105-08     Document Type: Article

References (39)

1. Al Dgither, S., S. N. Alvi, and M. M. Hammami. 2006. Development and validation of an HPLC method for the determination of gatifloxacin stability in human plasma. J. Pharm. Biomed. Anal. 41:251-255.
2. Amaral, L., M. Martins, and M. Viveiros. 2007. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J. Antimicrob. Chemother. 59:1239-1246.
3. Asakura, E., H. Nakayama, M. Sugie, Y. L. Zhao, M. Nadai, K. Kitaichi, A. Shimizu, M. Miyoshi, K. Takagi, K. Takagi, and T. Hasegawa. 2004. Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats. Eur. J. Pharmacol. 484:333-339.
4. Cao, C. X., S. C. Silverstein, H. C. Neu, and T. H. Steinberg, 1992. J774 macrophages secrete antibiotics via organic anion transporters. J. Infect. Dis. 165:322-328.
5. Carryn, S., F. Van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2002. Comparative intracellular (THP-1 macrophage) and extracellular activities of β-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrob. Agents Chemother. 46:2095-2103.
6. Cunningham, R. F., Z. H. Israili, and P. G. Dayton. 1981. Clinical pharmacokinetics of probenecid. Clin. Pharmacokinet. 6:135-151.
7. Deeley, R. G., and S. P. Cole. 2006. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 580:1103-1111.
8. Ebert, B., A. Seidel, and A. Lampen. 2005. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26:1754-1763.
9. Ekins, S., R. B. Kim, B. F. Leake, A. H. Dantzig, E. G. Schuetz, L. B. Lan, K. Yasuda, R. L. Shepard, M. A. Winter, J. D. Schuetz, J. H. Wikel, and S. A. Wrighton. 2002. Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates. Mol. Pharmacol. 61:974-981.
10. Godreuil, S., M. Galimand, G. Gerbaud, C. Jacquet, and P. Courvalin. 2003. Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob. Agents Chemother. 47:704-708.
11. Gollapudi, S., C. H. Kim, B. N. Tran, S. Sangha, and S. Gupta. 1997. Probenecid reverses multidrug resistance in multidrug resistance- associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells. Cancer Chemother. Pharmacol. 40:150-158.
12. Grayo, S., O. Join-Lambert, M. C. Desroches, and A. Le Monnier. 2008. Comparison of the in vitro efficacies of moxifloxacin and amoxicillin against Listeria monocytogenes. Antimicrob. Agents Chemother. 52:1697-1702.
13. Guinane, C. M., P. D. Cotter, R. P. Ross, and C. Hill. 2006. Contribution of penicillin-binding protein homologs to antibiotic resistance, cell morphology, and virulence of Listeria monocytogenes EGDe. Antimicrob. Agents Chemother. 50:2824-2828.
14. Henderson, G. B., T. R. Hughes, and M. Saxena. 1995. Distinct systems mediate the unidirectional efflux of methotrexate and cholate in human CCRF-CEM cells. Arch. Biochem. Biophys. 316:77-82.
15. Kohda, C., Y. Yanagawa, and T. Shimamura. 2008. Epigallocatechin gallate inhibits intracellular survival of Listeria monocytogenes in macrophages. Biochem. Biophys. Res. Commun. 365:310-315.
16. Krishna, R., and L. D. Mayer. 2000. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 11:265-283.
17. Kruh, G. D., H. Zeng, P. A. Rea, G. Liu, Z. S. Chen, K. Lee, and M. G. Belinsky. 2001. MRP subfamily transporters and resistance to anticancer agents. J. Bioenerg. Biomembr. 33:493-501.
18. Lee, C. H. 2004. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Curr. Med. Chem. Anticancer Agents 4:43-52.
19. Lee, E. W., M. N. Huda, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis. Antimicrob. Agents Chemother. 47:3733-3738.
20. Lemaire, S., F. Van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2007. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and Madin-Darby canine kidney cells. Antimicrob. Agents Chemother. 51:2748-2757.
21. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
22. Michot, J. M., M. F. Heremans, N. E. Caceres, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2006. Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophages. Antimicrob. Agents Chemother. 50:1689-1695.
23. Michot, J. M., C. Seral, F. Van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2005. Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages. Antimicrob. Agents Chemother. 49:2429-2437.
24. Michot, J. M., F. Van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2004. Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter. Antimicrob. Agents Chemother. 48:2673-2682.
25. Neyfakh, A. A., C. M. Borsch, and G. W. Kaatz. 1993. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother. 37:128-129.
26. O'Connor, R., M. O'Leary, J. Ballot, C. D. Collins, P. Kinsella, D. E. Mager, R. D. Arnold, L. O'Driscoll, A. Larkin, S. Kennedy, D. Fennelly, M. Clynes, and J. Crown. 2007. A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. Cancer Chemother. Pharmacol. 59:79-87.
27. Ouadrhiri, Y., B. Scorneaux, Y. Sibille, and P. M. Tulkens. 1999. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob. Agents Chemother. 43:1242-1251.
28. Piddock, L. J., M. M. Johnson, S. Simjee, and L. Pumbwe. 2002. Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:808-812.
29. Seral, C., M. Barcia-Macay, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2005. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. J. Antimicrob. Chemother. 55:511-517.
30. Seral, C., S. Carryn, P. M. Tulkens, and F. Van Bambeke. 2003. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. J. Antimicrob. Chemother. 51:1167-1173.
31. Teodori, E., S. Dei, C. Martelli, S. Scapecchi, and F. Gualtieri. 2006. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR). Curr. Drug Targets 7:893-909.
32. Tyteca, D., P. Van Der Smissen, M. Mettlen, F. Van Bambeke, P. M. Tulkens, M. P. Mingeot-Leclercq, and P. J. Courtoy. 2002. Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages. Exp. Cell Res. 281:86-100.
33. Van Bambeke, F., E. Balzi, and P. M. Tulkens. 2000. Antibiotic efflux pumps. Biochem. Pharmacol. 60:457-470.
34. Van Bambeke, F., Y. Glupczynski, P. Plesiat, J. C. Pechere, and P. M. Tulkens. 2003. Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J. Antimicrob. Chemother. 51:1055-1065.
35. Van Bambeke, F., J. M. Michot, and P. M. Tulkens. 2003. Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics. J. Antimicrob. Chemother. 51:1067-1077.
36. Van Bambeke, F., J. M. Pages, and V. J. Lee. 2006. Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Patents Anti-Infect. Drug Discov. 1:157-175.
37. Versantvoort, C. H., H. J. Broxterman, J. Lankelma, N. Feller, and H. M. Pinedo. 1994. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem. Pharmacol. 48:1129-1136.
38. Wang, E. J., C. N. Casciano, R. P. Clement, and W. W. Johnson. 2001. Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors. Biochem. Biophys. Res. Commun. 289:580-585.
39. Yasuda, K., L. B. Lan, D. Sanglard, K. Furuya, J. D. Schuetz, and E. G. Schuetz. 2002. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. J. Pharmacol. Exp. Ther. 303:323-332.